Julia K. Locklin

National Institutes of Health

Papers

1

Total Citations

145

H-Index

1

About

Julia K. Locklin is a leading figure in interventional oncology, with a primary focus on advancing image-guided therapies for cancer treatment. Her seminal work, "Technologies for Guidance of Radiofrequency Ablation in the Multimodality Interventional Suite of the Future" (2007, 145 citations), laid critical groundwork for integrating multiple imaging modalities—such as CT, MRI, and ultrasound—to enhance the precision and efficacy of radiofrequency ablation. This contribution has been instrumental in shaping modern interventional suites, enabling real-time, multi-dimensional guidance that improves tumor targeting and reduces procedural risks. Locklin’s research has significantly impacted the field by bridging engineering and clinical practice, fostering safer, more effective minimally invasive cancer treatments. Her work continues to influence the design of next-generation interventional platforms, making her a key innovator in the evolution of image-guided oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
145
Total Citations
145
Avg Citations/Paper
🏆 Most Cited Paper
Technologies for Guidance of Radiofrequency Ablation in the Multimodality Interventional Suite of the Future
145 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago